Literature DB >> 22898639

A new approach for evaluating the resectability of pancreatic and periampullary neoplasms.

Chi-hua Fang1, Wen Zhu, Huaizhi Wang, Nan Xiang, Yingfang Fan, Jian Yang, Xiaojun Wang, Shi zheng Zhong.   

Abstract

OBJECTIVE: To establish a new standard for assessing the resectability of pancreatic and periampullary tumors by the Medical Image Three-Dimensional Visualization System (MI-3DVS).
METHODS: Eighty cases of pancreatic and periampullary tumors were examined. The 64-slice multidetector CT (64-MDCT) images and patient data were processed by MI-3DVS. The main elements examined by MI-3DVS included tumor shape, size, and location; distribution of related vessels; luminal morphology of large vessels; distribution and morphology of the small peripancreatic veins; morphology, degree of dilation, and obstructive sites of bile and pancreatic ducts. Based on vascular characteristics of MI-3DVS findings, the cases were classified into five types. Type I and II were resectable, type III were potentially resectable or resectable with combined vascular resection and reconstruction, and type IV and V were unresectable. The outcome was then compared with corresponding CT angiography (CTA) analysis and actual surgical observations.
RESULTS: Among the 80 cases, MI-3DVS indicated that 60 were resectable and the remaining 20 were not. In contrast, CTA indicated 50 resectable cases and 30 unresectable cases. For 57 cases of pancreatic ductal carcinomas and all 80 cases periampullary tumors, MI-3DVS assessment yielded a positive predictive value of 100%, negative predictive value of 100%, a sensitivity of 100%, a specificity of 100%, and an accuracy of 100%. While CTA generated corresponding values of 96%, 60%, 80%, 90%, 82.5%. The overall differences between the two methods were significant (P < 0.05).
CONCLUSION: The new classification system is able to reliably assess the resectability of pancreatic and periampullary tumors.
Copyright © 2012 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22898639     DOI: 10.1016/j.pan.2012.05.006

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  8 in total

1.  Performance of CT-based radiomics in diagnosis of superior mesenteric vein resection margin in patients with pancreatic head cancer.

Authors:  Yun Bian; Hui Jiang; Chao Ma; Kai Cao; Xu Fang; Jing Li; Li Wang; Jianming Zheng; Jianping Lu
Journal:  Abdom Radiol (NY)       Date:  2020-03

2.  Body Mass Index and Stump Morphology Predict an Increased Incidence of Pancreatic Fistula After Pancreaticoduodenectomy.

Authors:  Chi-Hua Fang; Qing-Shan Chen; Jian Yang; Fei Xiang; Zhao-Shan Fang; Wen Zhu
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

3.  The effectiveness of using 3D reconstruction software for surgery to augment surgical education.

Authors:  Ryan Bailer; Robert C G Martin
Journal:  Am J Surg       Date:  2019-08-06       Impact factor: 3.125

Review 4.  Diagnostic Laparoscopy with Ultrasound Still Has a Role in the Staging of Pancreatic Cancer: A Systematic Review of the Literature.

Authors:  Jordan Levy; Mehdi Tahiri; Tsafrir Vanounou; Geva Maimon; Simon Bergman
Journal:  HPB Surg       Date:  2016-03-30

5.  Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.

Authors:  Inne Somers; Shandra Bipat
Journal:  Eur Radiol       Date:  2017-01-16       Impact factor: 5.315

Review 6.  Role of artificial intelligence in hepatobiliary and pancreatic surgery.

Authors:  Hassaan Bari; Sharan Wadhwani; Bobby V M Dasari
Journal:  World J Gastrointest Surg       Date:  2021-01-27

7.  A Comparison between Three-Dimensional Visualization Guided Hepatectomy and Ultrasonography Guided Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma within the Milan Criteria.

Authors:  Tian-Pei Guan; Chi-Hua Fang; Jian Yang; Nan Xiang; Qing-Shan Chen; Shi-Zhen Zhong
Journal:  Biomed Res Int       Date:  2016-05-12       Impact factor: 3.411

8.  Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma.

Authors:  Yan Yang; Zhongyin Zhou; Rong Liu; Lu Chen; Hongyu Xiang; Na Chen
Journal:  Exp Ther Med       Date:  2018-02-02       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.